Getting Investigational Drugs to Patients in Decentralized Clinical Trials: Solutions and Key IRT Considerations

Life Sciences, Clinical Trials, Patient Recruitment & Retention, Drug Discovery & Development,
  • Thursday, April 15, 2021

The COVID-19 pandemic has accelerated the adoption of decentralized clinical trials (DCTs), which was already increasing due to the benefits of convenience, greater access to treatments by patients, greater access to a more representative population by investigators and reduced burden on site staff. One of the challenges with remote visits is the distribution, tracking, reconciliation and destruction of the investigational medicinal product (IMP), while maintaining the blinding and patient confidentiality. To address this challenge, operational and technological strategies have been implemented in many trials. However, interactive response technology (IRT) solution also has a big role to play in any solution required to support DCTs, today and in the future.

Register for this webinar to hear about the role of interactive response technology in supporting decentralized clinical trials.



Susan Rizzo, Director, Service Delivery RTSM, Bioclinica

Sue is a recognized leader in the eClinical space with more than 30 years of operational and clinical leadership experience, the last 20 years of which have been in the high-growth eClinical technology space. In her current role, Sue is responsible for the successful delivery of projects within the Randomization & Trial Supply Management (RTSM) business, encompassing Bioclinica’s innovative IRT platform, clinical supply forecasting, and optimization. Prior to Bioclinica, Sue led the U.S.-based Project Management RTSM team at PAREXEL Informatics. Before that, Sue was with ClinPhone for close to ten years focused on RTSM before being acquired by PAREXEL in 2008. Early in her career, she worked as an RN in critical care and cardiology both as a staff nurse, Nurse Leader and Study Coordinator at large academic medical centers in NY state. Sue has a degree in Nursing from the State University of New York (Canton) and is a licensed RN in NY state.

Message Presenter

Who Should Attend?

This webinar is suitable for managers, leads and other relevant job titles in the following departments:

  • Clinical Supply
  • RTSM
  • Interactive Response Technology
  • Clinical Trial
  • Clinical Operations
  • Clinical Outsourcing
  • Clinical Technology
  • Data Management
  • Regulatory
  • Site Management
  • Clinical Monitoring
  • TA Head
  • Medical Monitors
  • Clinical Scientists
  • Imaging or Biomarkers Scientists
  • Heads of: R&D, Clinical Research, Clinical Development, Clinical Operations
  • Study/Project Manager
  • Protocol Manager
  • Study Startup

What You Will Learn

In this webinar, panelists will discuss:

  • The challenges of implementing direct-to-patient shipment of IMP
  • The pros and cons of Implemented Strategies
  • An outline of the key considerations for an IRT solution to support hybrid or full DCT implementations

Xtalks Partner


Bioclinica is a global, life-science provider that utilizes science and technology to reduce risk of clinical trials – helping companies to develop new, life-improving therapies more efficiently and safely. The company’s offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance, and trial management.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account